Prosecution Insights
Last updated: August 18, 2026

Examiner: KIM, YOUNG J

Tech Center 3600 • Art Units: 1637 1681 3619

This examiner grants 65% of resolved cases

Performance Statistics

64.8%
Allow Rate
+12.8% vs TC avg
1,177
Total Applications
+18.0%
Interview Lift
1159
Avg Prosecution Days
Based on 1117 resolved cases, 2023–2026

Rejection Statute Breakdown

5.6%
§101 Eligibility
11.6%
§102 Novelty
37.2%
§103 Obviousness
33.8%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18447749 METHODS AND COMPOSITIONS FOR DETECTING NUCLEIC ACID VARIANTS Non-Final OA Guardant Health, Inc.
18653613 METHODS AND COMPOSITIONS FOR SPATIAL ASSAY Non-Final OA 10x Genomics, Inc.
18418967 METHODS OF MAKING GENE EXPRESSION LIBRARIES Non-Final OA 10x Genomics, Inc.
17956596 METHODS AND KITS FOR IDENTIFYING, DIAGNOSING AND TREATING PROSTATE CARCINOMAS Final Rejection 10x Genomics, Inc.
18043012 PORTABLE DETECTION OF SARS-COV-2 USING UNIMOLECULAR APTASENSORS Non-Final OA ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
17879871 Ultraspecific Nucleic Acid Sensors for Low-Cost Liquid Biopsies Final Rejection ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
17557010 METHOD FOR PROVIDING QUANTITATIVE INFORMATION OF TARGETS AND DEVICE USING THE SAME Final Rejection KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY
18403634 TUMOR SUPPRESSOR SP0495 Non-Final OA The Chinese University of Hong Kong
18468298 COMPOSITIONS AND METHODS FOR CHARACTERIZING LYMPHOMA AND RELATED CONDITIONS Non-Final OA The General Hospital Corporation
18534106 METHODS FOR DETECTING MODIFIED NUCLEOTIDES Non-Final OA CAMBRIDGE ENTERPRISE LIMITED
18722508 DETECTION OF GENETIC AND EPIGENETIC INFORMATION IN A SINGLE WORKFLOW Non-Final OA Foundation Medicine, Inc.
18712646 METHODS AND SYSTEMS FOR REPORTING CLINICALLY-ACTIONABLE POTENTIAL GERMLINE PATHOGENIC VARIANT SEQUENCES Non-Final OA Foundation Medicine, Inc.
18561986 ENHANCER OLIGONUCLEOTIDES FOR NUCLEIC ACID HYBRIDIZATION Non-Final OA Roche Sequencing Solutions, Inc
18029937 METHOD FOR VIRUS DETECTION Non-Final OA Qiagen GmbH

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month